Anebulo Pharmaceuticals, Inc. Common Stock
Symbol: ANEB (NASDAQ)
2.48
▲ (2.52%) 0.061
Company Description:
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
Key Stats
- Today's Open: $2.44
- Today's High: $2.515
- Today's Low: $2.39
- Today's Volume: 56.30K
- Yesterday Close: $2.42
- Yesterday High: $2.42
- Yesterday Low: $2.34
- Yesterday Volume: 11.67K
- Last Min Volume: 2
- Last Min High: $2.497
- Last Min Low: $2.481
- Last Min VWAP: $2.497
Company Profile
- Name: Anebulo Pharmaceuticals, Inc. Common Stock
- Website: https://www.anebulo.com
- Listed Date: 2021-05-07
- Location: LAKEWAY, TX
- Market Status: Active
- CIK Number: 0001815974
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $99.43M
- Round Lot: 100
- Outstanding Shares: 41.08M
- Asset Type: CS
RECENT FILINGS FOR ANEB
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | 10-K | View |
| 2025-09-29 | 8-K | View |
| 2025-09-26 | S-8 POS | View |
| 2025-09-26 | S-8 POS | View |
| 2025-09-23 | EFFECT | View |
| 2025-09-23 | EFFECT | View |
| 2025-09-19 | POS AM | View |
| 2025-09-19 | POS AM | View |
| 2025-09-15 | SC 13E3/A | View |
| 2025-09-15 | PRER14A | View |
| 2025-09-12 | 8-K | View |
| 2025-07-23 | 8-K | View |
| 2025-07-23 | SC 13E3 | View |
| 2025-07-23 | PRE 14A | View |
| 2025-05-15 | S-8 | View |
| 2025-05-13 | 10-Q | View |
| 2025-05-13 | 8-K | View |
| 2025-04-15 | 8-K | View |
| 2025-04-14 | 8-K | View |
| 2025-04-07 | 4 | View |
Latest News on ANEB